*For medical professionals only
According to the latest statistics from the World Health Organization's International Agency for Research on Cancer (IARC), there were 19.96 million new cancer cases and 9.74 million cancer deaths worldwide in 2022. Among them, there were 2.48 million new cases of lung cancer, accounting for 12.4% of the total number of new cancer cases in the world, making it the world's largest cancer again. An estimated 1.8 million people died from lung cancer, accounting for 18.7% of all global cancer deaths in 2022, posing a serious threat to human health.
In the past 20 years, the concept of "precision medicine" has represented a great breakthrough in the concept of tumor diagnosis and treatment. In particular, with the rapid development of genetic testing and molecular pathology technology, many tumor driver genes and mutation targets have been successfully discovered and applied in clinical practice. In this context, targeted therapy and immunotherapy have rapidly revolutionized the field of lung cancer treatment, and their standardized diagnosis and treatment and latest research progress have attracted great attention from the medical community.
The first LC+ Academic Week series will be held on April 20-21. This conference focuses on the treatment strategies of advanced lung cancer, combined with the hot information of recent international conferences such as the European Conference on Lung Cancer (ELCC) and the American Association for Cancer Research (AACR) annual meeting, and explores the optimal diagnosis and treatment plan of "patient-centered" through innovation.
With the theme of "Diagnosis and Treatment Upgrade, Joint Efforts to Achieve Long-term Results", the conference will invite well-known domestic experts and scholars to give keynote speeches and new progress reports, which will be a platform integrating learning, communication and cooperation, and provide an opportunity for all participants to share knowledge, experience and results. Through this conference, participants will have a deeper understanding of the latest advances in lung cancer treatment, broaden their horizons, and improve the level of diagnosis and treatment to better serve patients.
Let's look forward to this academic feast of big names and witness the new breakthroughs and new developments in the treatment of advanced lung cancer!At 13:30 on April 20, 2024 (Saturday), we will see you at the first LC+ Academic Week series of "Diagnosis and Treatment Upgrades, Working Together to Achieve Long-term"!
Exciting information is waiting for you
* This article is only for the purpose of providing scientific information to medical professionals and does not represent the views of this platform
